European companies present their cancer treatment solutions in the USA

By Joachim Eeckhout

Each year, the American Society of Clinical Oncology gathers the cancer therapy developers during five days to present their latest results. Roche seems to be the European winner of this roundup, with amazing results of alectinib in non-small cell lung cancer (NSCLC). Roche’s investigational medicine alectinib shrank tumors in Lire la suite

Source:: Labiotech

Les commentaires sont clos.